(IN BRIEF) A study conducted by researchers at the University of York and University of Sheffield found that common childhood phobias, such as fear of spiders, dogs, and needles, could be resolved in a single three-hour therapy session instead of … Read the full press release
Mydayis, which is now available in the U.S., demonstrated improvements lasting up to 16 hours post-dose, beginning at 2 or 4 hours post-dose, compared to placebo, in total score on a skill-adjusted math test that measures attention in ADHD Lexington, … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech
Tagged ADHD, Dr. Matthew Brams, MYDAYIS, Shire
LEICESTERSHIRE, 06-Jul-2017 — /EuropaWire/ — Following a daily movement programme can improve children’s physical development levels and has the potential to boost their chances in the classroom, researchers from Loughborough University have found. Academics from the University’s School of Sport, Exercise and … Read the full press release
Research group offers new insights into the roles of different subareas in the prefrontal cortex FREIBERG, 14-Feb-2017 — /EuropaWire/ — Whether the brain responds to an external stimulus or not depends significantly on the balance between areas of excitation and inhibition … Read the full press release
Posted in Education, Germany, Healthcare, Science
Tagged ADHD, decision-making, OCD, prefrontal cortex, Professor Ilka Diester, Stefanie Hardung, University of Freiburg
Lexington, Mass., USA, 20-Jan-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for SHP465, a long-acting, triple-bead, … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech
Tagged ADHD, Andrew J. Cutler MD, New Drug Application, PDUFA, Philip Vickers PhD, Prescription Drug User Fee Act, Shire plc, SHP465, U.S. FDA
https://youtu.be/sx11gbYMRFs Spoken word performer communicates plight of adults with ADHD who remain overlooked and unsupported. ZUG, 25-Oct-2016 — /EuropaWire/ — To mark ADHD Awareness Month, Shire plc (LSE: SHP, NASDAQ: SHPG) has today launched a powerful spoken word video to communicate … Read the full press release
Posted in Healthcare, Non Profit, Society, Switzerland
Tagged ADHD, adults ADHD, powerful spoken word video, raise awareness, Shire
GENEVA, 08-Jun-2016 — /EuropaWire/ — TESTmyBRAIN (Switzerland) has opened its first center of Functional Neurology in Europe. This non-invasive therapy (no medication, no surgery) coming from the United States helps patients suffering from migraines, concussions, strokes, AD/HD, Parkinson disease, Alzheimer, … Read the full press release
Posted in Education, Germany, Healthcare, Netherlands, News, Sports, Switzerland, United Kingdom
Tagged ADHD, Alzheimer, central nervous system, Concussions, dizziness, headaches, migraines, Mr. Claude Martinet, Parkinson, stroke, Switzerland, TESTmyBRAIN, testmybrain.ch
15-11-2012 — /europawire.eu/ — A group of scientists from the University of Copenhagen has created a model that shows how some types of ADHD medicine influence the brain’s reward system. The model makes it possible to understand the effect of the medicine … Read the full press release
Posted in Denmark, Education, Healthcare, Pharma & Biotech, Science
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
